Immune medicines hold promise as therapies for debilitating disorders such as cancer, infectious diseases, and inflammatory diseases. By studying immune cell subsets, researchers gain insights into which patients will respond to various immunotherapies. To accelerate the timelines for finding cures, scientists use applications that decrease the space and time needed for assays that target single immune cells.
In this event brought to you by IsoPlexis, industry and academic leaders describe how data from small immune cell subsets shift conceptions about how humans mount effective immune responses, including which cells orchestrate a balanced attack. They discuss technological advancements that enable researchers to use functional proteomes to detect powerful, highly active immune cell subsets. Additionally, the speakers highlight applications for harnessing these powerful cell subsets to advance cell and gene therapies.